Abstract
Great advances have been made in describing the intracellular pathways and genes that are activated by bacterial products. New definitions and therapies for sepsis will be based on such cellular and genetic alterations. In particular, in 2051 sepsis will no longer be defined simply as a clinical constellation of findings, but rather will be divided into different entities dependent on the intracellular cascades or genes activated. Similarly, therapies will be specifically directed at such functional genetic or biochemical alterations, thereby permitting more rational therapy of specific cellular abnormalities in infected patients. Supportive care will also have advanced by 2051, allowing for less iatrogenic harm to critically ill septic patients. Finally, a better appreciation of the cellular and genetic pathways that are activated in patients will permit an improved understanding of prognosis in critically ill infected patients, allowing more appropriate use of therapies.
Highlights
I do not think there will be something called ‘sepsis’ in 2051 because we will know much more about this entity than we do at present
This article is based on a presentation at the 31st Annual Congress of the Society of Critical Care Medicine (SCCM), San Diego, California, USA, 26–30 January 2002
The presentation was supported by the International Sepsis Forum (ISF)
Summary
I do not think there will be something called ‘sepsis’ in 2051 because we will know much more about this entity than we do at present. This article is based on a presentation at the 31st Annual Congress of the Society of Critical Care Medicine (SCCM), San Diego, California, USA, 26–30 January 2002. The presentation was supported by the International Sepsis Forum (ISF).
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
